European Union - English - EMA (European Medicines Agency)

baxalta innovations gmbh - vonicog alfa - von willebrand diseases - antihemorrhagics - veyvondi is indicated in adults (age 18 and older) with von willebrand disease (vwd), when desmopressin (ddavp) treatment alone is ineffective or not indicated for the- treatment of haemorrhage and surgical bleeding- prevention of surgical bleeding.veyvondi should not be used in the treatment of haemophilia a.

Canada - English - Health Canada

takeda canada inc - von willebrand factor (recombinant) - powder for solution - 650unit - von willebrand factor (recombinant) 650unit - hemostatics

Canada - English - Health Canada

takeda canada inc - von willebrand factor (recombinant) - powder for solution - 1300unit - von willebrand factor (recombinant) 1300unit - hemostatics

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - human factor von willebrand 100 iu - powder and solvent for solution for injection - 1000 iu/10 ml - factor von willebrand 100 iu/ml - von willebrand factor

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lfb biopharmaceuticals ltd - von willebrand factor - powder and solvent for solution for injection - 1000unit